findmyKOL

Zeenat Safdar, MD

Enriched profile

Professor of Medicine, Houston Methodist Academic Institute (Ashley Lain Barras Distinguished Chair in Pulmonology, Charles W. Duncan Jr. Department of Medicine); Medical Director, Houston Methodist Lung Center; Director, Clinical Research and Pulmonary Hypertension Program · Houston Methodist Hospital

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceNone verifiedPayments2021–2025NIH funding2010–2014

Zeenat Safdar is Professor of Medicine, Houston Methodist Academic Institute (Ashley Lain Barras Distinguished Chair in Pulmonology, Charles W. Duncan Jr. Department of Medicine); Medical Director, Houston Methodist Lung Center; Director, Clinical Research and Pulmonary Hypertension Program at Houston Methodist Hospital. OpenAlex indexes 137 publications with 4,520 citations (h-index 27); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Zeenat Safdar, MD, is Professor of Medicine, Houston Methodist Academic Institute (Ashley Lain Barras Distinguished Chair in Pulmonology, Charles W. Duncan Jr. Department of Medicine) at Houston Methodist Hospital / Houston Methodist Academic Institute, Houston, TX. The public record shows 137 publications with 4,520 citations (h-index 27), centered on Respiratory. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 24 companies, 1 NIH-funded awards (2010–2014).

  • Most recent indexed publication: 2024 · Case reports in pulmonology
  • Top research focus: Respiratory
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 24 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Idiopathic Pulmonary Fibrosis1 trialLung Diseases, Interstitial1 trialHypertension1 trialPulmonary Hypertension1 trial

Research focus

OpenAlex concept fingerprint
Respiratory

Drugs & molecules

across trials, industry payments and publications
Uptravigeneric · SelexipagClinical trials—Industry payments91Publications1Tyvasogeneric · TreprostinilClinical trials—Industry payments84Publications1Opsumitgeneric · MacitentanClinical trials—Industry payments99Publications—Ofevgeneric · NintedanibClinical trials—Industry payments27Publications—Nucalageneric · MepolizumabClinical trials—Industry payments11Publications—Adempasgeneric · RiociguatClinical trials—Industry payments10Publications—Arikaycegeneric · AmikacinClinical trials—Industry payments8Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments4Publications—Aralastgeneric · Alpha 1-antitrypsinClinical trials—Industry payments3Publications—Yupelrigeneric · RevefenacinClinical trials—Industry payments3Publications—Avycazgeneric · Avibactam / ceftazidimeClinical trials—Industry payments2Publications—Jascaydgeneric · NerandomilastClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
United Therapeutics CorporationClinical trials—Industry payments118Actelion Pharmaceuticals US, Inc.Clinical trials—Industry payments99Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments58Merck Sharp & Dohme LLCClinical trials—Industry payments18GlaxoSmithKline, LLC.Clinical trials—Industry payments12Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments10Insmed, Inc.Clinical trials—Industry payments8Sandoz Inc.Clinical trials—Industry payments7Johnson & Johnson Health Care Systems Inc.Clinical trials—Industry payments4Pfizer Inc.Clinical trials—Industry payments4Mylan Specialty L.P.Clinical trials—Industry payments3Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments3Abbvie Inc.Clinical trials—Industry payments2AstraZeneca Pharmaceuticals LPClinical trials—Industry payments2Baxter HealthcareClinical trials—Industry payments2Grifols USA, LLCClinical trials—Industry payments2Inogen, Inc.Clinical trials—Industry payments2Liquidia Technologies, Inc.Clinical trials—Industry payments2Ambu Inc.Clinical trials—Industry payments1Baylor College of MedicineClinical trials1Industry payments—Duke UniversityClinical trials1Industry payments—Inari Medical, Inc.Clinical trials—Industry payments1Pharming Healthcare, Inc.Clinical trials—Industry payments1Salix Pharmaceuticals, a division of Bausch Health US, LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
137publications

Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.

4,520citations

Total citations across indexed works.

27h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
24companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2010–2014

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

24 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    37.1%
    Endothelin Receptor Antagonist18.8%
    Opsumit80%Letairis10%Ambrisentan10%
    Part D<11 patients
    Loop diuretic4.5%
    Furosemide100%
    Part D≥43 patients

    + 7 more classes in this area

  • Blood & clotting

    14.1%
    Prostacycline Vasodilator6.5%
    Orenitram Er68%Tyvaso Dpi32%
    Part D<11 patients
    Prostacyclin Receptor Agonist6.2%
    Uptravi100%
    Part D≥19 patients

    + 1 more class in this area

  • Respiratory

    12.3%
    Corticosteroid7%
    Breo Ellipta48%Trelegy Ellipta34%Symbicort11%Fluticasone Propionate8%
    Part D<11 patients
    Leukotriene Receptor Antagonist4.5%
    Montelukast Sodium100%
    Part D≥40 patients

    + 1 more class in this area

All 9 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)93.9% facility · 6.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2010–2014 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • LinkedIn

    linkedin.com/posts/houston-methodist_our-professor-of-medicine-dr-zeenat-safdar-activity-7179115591771852802-pgBK

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile: Zeenat Safdar, MD, MS, ATSF, Weill Cornell Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • ResearchGate

    ResearchGate profile listing Baylor College of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine (legacy/prior affiliation)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
  • MD

    SUNY Downstate Health Science Center (Brooklyn, NY); fellowship, Columbia University College of Physicians & Surgeons at St. Luke's-Roosevelt Hospital Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hilarispublisher.com ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →directory.curehht.org ↗
  • Board certified

    Critical Care Medicine (also practices Pulmonary Disease and Internal Medicine)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.